LA VILLA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 6.019
EU - Europa 3.146
AS - Asia 664
OC - Oceania 60
AF - Africa 30
SA - Sud America 1
Totale 9.920
Nazione #
US - Stati Uniti d'America 6.003
RU - Federazione Russa 1.137
SE - Svezia 466
IE - Irlanda 401
PL - Polonia 262
UA - Ucraina 256
SG - Singapore 238
IT - Italia 202
HK - Hong Kong 198
DE - Germania 175
FI - Finlandia 103
CN - Cina 89
IN - India 66
AU - Australia 60
GB - Regno Unito 57
CH - Svizzera 49
TR - Turchia 35
FR - Francia 22
CI - Costa d'Avorio 21
JO - Giordania 21
CA - Canada 13
NL - Olanda 7
BE - Belgio 6
SC - Seychelles 6
ID - Indonesia 4
KR - Corea 4
VN - Vietnam 4
MX - Messico 3
EG - Egitto 2
IR - Iran 2
LT - Lituania 2
TH - Thailandia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
JP - Giappone 1
MU - Mauritius 1
Totale 9.920
Città #
Santa Clara 1.500
Fairfield 624
Chandler 427
Jacksonville 414
Dublin 401
Woodbridge 322
Ashburn 291
Cambridge 283
Seattle 270
Warsaw 262
Wilmington 237
Houston 236
Singapore 203
Hong Kong 106
Princeton 102
Ann Arbor 93
Boardman 82
Boston 75
Buffalo 70
Melbourne 60
Lawrence 56
Bern 49
Altamura 46
Mumbai 46
Beijing 44
Medford 43
San Diego 40
Izmir 27
Abidjan 21
Milan 21
Shanghai 20
Norwalk 19
Florence 18
Los Angeles 16
Moscow 14
Auburn Hills 13
Falls Church 13
Bremen 12
Dearborn 11
Frankfurt Am Main 10
Kent 10
Andover 8
New York 8
Toronto 8
Verona 8
Yubileyny 8
Salerno 7
Brussels 6
Hillsboro 6
Washington 6
London 5
Dong Ket 4
Pune 4
Frankfurt am Main 3
Laurel 3
Munich 3
Riardo 3
Ahmedabad 2
Banda Aceh 2
Brescia 2
Cairo 2
Cedar Hill 2
Guangzhou 2
Jakarta 2
Kolkata 2
Kunming 2
Naaldwijk 2
Nakhon Ratchasima 2
Nanjing 2
New Delhi 2
Padova 2
Reynosa 2
San Mateo 2
Taranto 2
West Jordan 2
Yuseong-gu 2
Agliana 1
Ardabil 1
Ashford 1
Atlanta 1
Bari 1
Bologna 1
Brno 1
Clifton 1
Comeana 1
Detroit 1
Dover 1
Genoa 1
Groningen 1
Hamburg 1
Hanover 1
Hefei 1
Helsinki 1
Hull 1
Huntsville 1
Kirkland 1
Levis 1
Mérida 1
Napanee 1
Ningbo 1
Totale 6.759
Nome #
Spiral computed tomography versus ultrasound in the follow up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study 259
THAD in biliary duct disease 250
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 151
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 144
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 144
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 137
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 136
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 135
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 129
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 128
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 127
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 127
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 126
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 122
Ascites and hepatorenal syndrome 121
Torasemide in the treatment of patients with cirrhosis and ascites. 121
Liver-kidney pathophysiological interrelationships in liver diseases. 121
Loop diuretic therapy in liver cirrhosis with ascites 119
T(14;18) translocation in chronic hepatitis C virus infection 118
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 118
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 118
Functional renal alterations in chronic liver diseases. 117
CARDIOVASCULAR EFFECTS OF PARATHYROID HORMONE: A STUDY IN HEALTHY SUBJECTS AND NORMOTENSIVE PATIENTS WITH MILD PRIMARY HYPERPARATHYROIDISM 116
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 115
Analysis of HCV persistence in patients with sustained virological response 114
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure 113
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 113
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 113
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 112
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 112
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 110
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 110
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 110
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 109
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 109
Pathogenesis and treatment of ascites in hepatic cirrhosis. 108
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 107
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 106
Hepato-systemic gradient of carbon monoxide in cirrhosis. 106
Uveitis in autoimmune hepatitis: a case report. 104
Hemodynamic alterations in liver cirrhosis. 103
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 101
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 100
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 100
Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. 100
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 99
Pathogenesis and management of the hepatorenal syndrome. 99
Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension. 99
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 99
Pathogenesis and treatment of ascites in hepatic cirrhosis. 97
Multiple immune disorders in unrecognized celiac disease: a case report 95
Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. 94
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 92
Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. 92
The kinin system and other vasoactive substances in chronic liver disease. 92
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 92
Renal impairement in chronic liver diseases with and without cholestasis 91
Hepatorenal syndrome and its treatment today. 91
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 90
Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. 89
Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension. 89
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 89
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 88
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 87
Systemic haemodynamics, renal and platelet function during chronic propranolol ADMINISTRATION IN PATIENTS WITH COMPENSATED CIRRHOSIS 87
Transient Hepatic Attenuation Differences - Pictorial Essay 86
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites 86
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 86
Dopamine and sympathoadrenal activity in man. 85
[Determination of prostaglandin E2 and F2 alpha in the urine of cirrhotic patients: comparison of 3 different chromatographic methods] 85
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 84
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. 84
Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. 83
Effects of acute clonidine administration on power spectral analysis of heart rate variability in healthy humans. 81
Arachidonic acid derivatives and renal function in liver cirrhosis. 81
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 80
Il Fegato: Fisiopatologia, Clinica, Terapia 79
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 77
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 77
Long course and prognostic factors of virus-induced cirrhosis of the liver. 71
Effects of OKY 046, a thromboxane-sinthase inhibitor, on renal function in non-azotemic cirrhotic patients with ascites 70
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 69
Refractory ascites: definition, pathogenesis and treatment. 67
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 64
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 63
Hemodynamic derangement and cardiac dysfunction in cirrhosis. 63
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 63
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 62
Low-dose C-natriuretic peptide does not affect cardiac and renal function in man 62
Renal Impairment In Chronic Liver-Diseases With And Without Cholestasis. 61
Persistence of HCV in hepatic and extrahepatic cells from asymptomatic non viremic chronic anti-HCV carriers. 60
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 59
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 59
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 59
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma 58
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. 58
Virological analysis of the healthy HCV carrier state: prognostic factors and HCV persistence in non viraemic subjects 58
Il fegato: fisiopatologia, clinica, terapia 56
pathogenetic factors of renal dysfuntion in chronic liver disease 51
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 50
Totale 9.847
Categoria #
all - tutte 25.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020931 0 0 0 0 0 206 160 200 136 82 128 19
2020/2021962 77 42 105 83 46 146 23 92 70 126 68 84
2021/2022636 11 77 20 21 20 32 21 35 31 23 162 183
2022/20231.746 163 191 93 126 177 321 241 113 186 14 58 63
2023/2024495 25 76 102 28 36 69 14 112 6 4 12 11
2024/20253.302 125 431 288 636 1.453 369 0 0 0 0 0 0
Totale 9.931